Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N1411)

Journal of Cell Biology

Volumn 139, Issue 2, 1997, Pages 485-495

  Janicki, Susan ^a   Monteiro, Mervyn J ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; PROTEIN PRECURSOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; MISSENSE MUTATION; MITOSIS; NONHUMAN; PRESENILE DEMENTIA; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BRAIN; CELL MEMBRANE; CLONING, MOLECULAR; DNA PRIMERS; ENDOPLASMIC RETICULUM; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; KINETICS; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTAGENESIS; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESENILIN-2; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; TRANSFECTION;

EID: 0030771534     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.139.2.485     Document Type: Article

References (60)

1. Alzheimer's Disease Collaborative Group. 1995. The structure of the Presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat. Genet. 11:219-222.
2. Borchelt, D.R., G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, T. Ratovitsky, C.-M. Prada, G. Kim, S. Seekins, D. Yager, et al. 1996. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1005-1013.
3. Boteva, K., M. Vitek, H. Mitsudade, H. Silva, P.-T. Xu, G. Small, and J.R. Gilbert. 1996. Mutation analysis of presenilin 1 gene in Alzheimer's disease. Lancet. 347:130-131.
4. Campion, D., J.M. Flaman, A. Brice, D. Hannequin, B. Dubois, C. Martin, V. Moreau, F. Charbonnier, O. Didierjean, S. Tardieu, et al. 1995. Mutations in the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4:2373-2377.
5. Chapman, J., A. Asherova, N. Wang, T.A. Treves, A.D. Korczyn, and L.G. Goldfarb. 1995. Familial Alzheimer's disease associated with S182 codon 286 mutation. Lancet. 346:1040.
6. Cook, D.B., J.C. Sung, T.E. Golde, K.M. Felsenstein, B.S. Wojczyk, R.E. Tanzi, J.Q. Trojanowski, V.M.Y. Lee, and R.M. Doms. 1996. Expression and analysis of presenilin-1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA. 93:9223-9228.
7. Corder, E.H., A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance. 1993. Gene dose apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (Wash. DC). 261:921-923.
8. Cruts, M., H. Backhovens, S. Y. Wang, G. Vangassen, J. Theurns, C. Dejonghe, A. Wehnert, J. Devoecht, G. deWinter, P. Cras, et al. 1995. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14Q24.3. Hum. Mol. Genet. 4:2363-2371.
9. Cruts, M., L. Hendriks, and C. Van Broeckhoven. 1996. The presenilin genes: a new gene family involved in Alzheimer's disease pathology. Hum. Mol. Genet. 5:1449-1455.
10. Deng, G., C.J. Pike, and C.W. Cotman. 1996. Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cell. FEBS Lett. 397:50-54.
11. Doan, A., G. Thinakaran, D.R. Borchelt, H.H. Slunt, T. Rativitsky, M. Podlisny, D.J. Selkoe, M. Seeger, S.E. Gandy, D.L. Price, and S.S. Sisodia. 1996. Protein topology of presenilin 1. Neuron. 17:1023-1030.
12. Duff, K., C. Eckman, C. Zehr, X. Yu, C.-M. Prada, J. Perez-tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, et al. 1996. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature (Lond.). 383:710-713.
13. Earnshaw, W.C. 1995. Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7: 337-343.
14. Graham, R., and A.J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:456-467.
15. Haass, C. 1997. Presenilins: genes for life and death. Neuron. 18:687-690.
16. Haass, C., Y. Hung, M, Citron, D.B. Teplow, and D.J. Selkoe. 1995. β-Amyloid, protein processing and Alzheimer's disease. Drug Res. 45:398-402.
17. Kaufmann, S.H. 1989. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49:5870-5878.
18. Kim, T.W., W.H. Pettingell, O.G. Hallmark, R.D. Moir, W. Wasco, and R.E. Tanzi, 1997. Endoproteolytic cleavage and proteosomal degradation of presenilin 2 transfected cells. J. Biol. Chem. 272:11006-11010.
19. Kovacs, D.M., H.J. Fausett, K.J. Page, T.-W. Kim, R.D. Moir, D.E. Merriam, R.D. Hollister, O.G. Hallmark, R. Mancini, K.M. Felsenstein, et al. 1996. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2: 224-229.
20. LaFerla, F.M., B.T. Tinkle, C.J. Bieberich, C. Haudenschild, and G. Jay. 1995. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:21-30.
21. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
22. Lazebnik, Y.A., R. Takahashi, R. Moir, R. Goldman, G. Poirier, S. Kaufmann, and W. Earnshaw. 1995. Studies of lamin proteinase reveal multiple parallel pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA. 92:9042-9046.
23. Lee, M.K., Z. Xu., P.C. Wong, and D.W. Cleveland. 1993. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122:1337-1350.
24. Lee, M.K., H.H. Slunt, L.J. Martin, G. Thinakaran, G. Kim, S.E. Gandy, M. Seeger, E. Koo, D.L. Price, and S.S. Sisodia. 1996. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16:7513-7525.
25. Lehmann, S., R. Chiesa, and D.A. Harris. 1997. Evidence for a six-transmembrane domain structure of presenilin 1. J. Biol Chem. 272:12047-12051.
26. Levitan, D., and I. Greenwald. 1995. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature (Lond.). 377:351-354.
27. Levitan, D., T.G. Doyle, D. Brousseau, M.K. Lee, G. Thinakaran, H.H. Slunt, S.S. Sisodia, and I. Greenwald. 1996. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 93:14940-14944.
28. Levy-Lahad, E., W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, W.H. Pettingell, C. Yu, P.D. Jondro, S.D. Schmidt, K. Wang, et al. 1995a. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science (Wash. DC). 269:973-977.
29. Levy-Lahad, E., E.M. Wijsman, E. Nemens, L. Anderson, K.A.B. Goddard, J.L. Weber, T.D. Bird, and G.D. Schellenberg. 1995b. A familial Alzheimer's disease locus on chromosome 1. Science (Wash. DC). 269:970-973.
30. Li, X., and I. Greenwald. 1996. Membrane topology of the C. elegans SEL-12 presenilin. Neuron. 17:1015-1021.
31. Li, J., J. Ma, and H. Potter. 1995. Identification and expression analysis of a potentially familial Alzheimer disease gene on chromosome 1 related to AD3. Proc. Natl. Acad. Sci. USA. 92:12180-12184.
32. Mercy, M.R., J.C. Troncoso, and M.J. Monteiro. 1992. A new series of trpE vectors that enable high expression of nonfusion proteins in bacteria. Protein Expr. Purif. 3:57-64.
33. Monteiro, M.J., and T. Mical. 1996. Resolution of kinase activities during the HeLa cell cycle: identification of kinases with cyclic activities. Exp. Cell Res. 223:443-451.
34. Monteiro, M.J., C. Hicks, L. Gu, and S. Janicfci. 1994. Determinants for intracellular sorting of cytoplasmic and nuclear intermediate filaments. J. Cell Biol. 127:1327-1343.
35. Mullan, M., and F. Crawford. 1993. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16:398-403.
36. Oberhammer, F.A., K. Hochegger, G. Froschl, R. Tiefenbacher, and M. Pavelka. 1994. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J. Cell Biol. 126:827-837.
37. Opas, M., E. Dziak, L. Fliegel, and M. Michalak. 1991. Regulation of expression and intracellular distribution of calreticulin, a major calcium binding protein of nonmuscle cells. J. Cell Physiol. 149:160-171.
38. Perez-Tur, J., S. Froelich, G. Prihar, R. Crook, M. Baker, K. Duff, M. Wragg, F. Busfield, C. Lendon, R.F. Clark, et al. 1995. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport. 7:297-301.
39. Rao, L., D. Perez, and E. White. 1996. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135:1441-1455.
40. Rogaev, E.I., R. Sherrington, E.A. Rogaeva, G. Levesque, M. Ikeda, Y. Liang, H. Chi, C. Lin, K. Holman, T. Tsuda, et al. 1995. Familial Alzheimer's disease in kindereds with missense mutations in the gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature (Lond.). 376:775-778.
41. Scheuner, D., C. Eckman, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, et al. 1996. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:864-870.
42. Shen, J., R.T. Bronson, D.F. Chen, W. Xia, D.J. Selkoe, and S. Tonegawa. 1997. Skeletal and CNS defects in presenilin-1-deficient mice. Cell. 89:629-639.
43. Sherrington, R., E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (Lond.). 375:754-760.
44. Sherrington, R., S. Froelich, S. Sorbi, D. Campion, H. Chi, E.A. Rogaeva, G. Levesque, E.I. Rogaev, C. Lin, Y. Liang, et al. 1996. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum. Mol. Genet. 5:985-988.
45. Strittmatter, W.J., and A.D Roses. 1995. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:4725-4727.
46. Su, J.H., G. Deng, and C.W. Cotman. 1997. Bax protein expression is increased in Alzheimer's brain: correlation with DNA damage, Bcl-2 expression, and brain pathology. J. Neuropathol. Exp. Neurol. 56:86-93.
47. Tamkun, M.M., K.M. Knoth, J.A. Wabridge, H. Kroemer, D.M. Roden, and K.M. Glover. 1991. Molecular cloning and characterization of two voltagegated K channel cDNAs from human ventricle. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:331-337.
48. Thinakaran, G., D.R. Borchelt, M.K. Lee, H.H. Slunt, L. Spitzer, G. Kim, T. Ratovitsky, F. Davenport, C. Nordstedt, M. Seeger, et al. 1996. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:181-190.
49. Tomita, T., K., Maruyama, T.C. Saido, H. Kume, K. Shinozaki, S. Tokuhiro, A. Capell, J. Walter, H. Grunberg, C. Hass, et al. 1997. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA. 94:2025-2030.
50. Ucker, D.S., J. Myers, and P.S. Obermiller. 1992. Activation driven cell death: quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J. Immunol 149:1583-1592.
51. Van Broeckhoven, C. 1995. Molecular genetics of Alzheimer's disease: identification of genes and gene mutations. Eur. Neurol. 35:8-19.
52. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science (Wash. DC). 271:521-525.
53. Vito, P., B. Wolozin, J.K. Ganjei, K. Iwasaki, E. Lacana, and L.D. D'Adamio. 1996b. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. J. Biol. Chem. 271:31025-31028.
54. Yamatsuji, T., T. Matsui, T. Okamoto, K. Komatsuzaki, S. Takeda, H. Fukumoto, T. Iwatsubo, N. Suziki, A. Asami-Odaka, S. Ireland, et al. 1996. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science (Wash. DC). 272:1349-1352.
55. Walter, J., A. Capell, J. Grunberg, B. Presold, A. Schindzielorz, R. Prior, M.B. Podlisny, P. Fraser, P.H. St. George-Hyslop, D.J. Selkoe, and C. Hass. 1996. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2:673-691.
56. Wasco, W., W.P. Pettingell, P.D. Jondro, S.D. Schmidt, S. Gurubhagavatula, L. Rodes, T. DiBlasi, D.M. Romano, S.Y. Guenette, D.M. Kovacs, et al. 1995. Familial Alzheimer's chromosome 14 mutations. Nat. Med. 1:848.
57. Wyllie, A.H. 1980. Cell death: significance of apoptosis. Int. Rev. Cytol. 68:251-306.
58. Wolozin, B., K. Iwasaki, P. Vito, J.K. Ganjei, E. Lacana, T. Sunderland, B. Zhao, J.W. Kusiak, W. Wasco, and L. D'Adamio. 1996. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (Wash. DC). 274:1710-1713.
59. Wong, P.C., H. Zeng, H. Chen, M.W. Becher, D.J.S. Sirinathsinghji, M.E. Trumbauer, H.Y. Chen, D.L. Price, L.H.T. Van der Ploeg, and S.S. Sisodia. 1997. Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm. Nature (Lond.). 387:288-292.
60. Xiao, J., and M.J. Monteiro. 1994. Identification and characterization of a novel (115 kDa) neurofilament-associated kinase. J. Neurosci. 14:1820-1833.